Zyversa Therapeutics Inc
ZVSA0.311USD
-0.238-43.30%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
799.48KMarket Cap
LossP/E TTM
Zyversa Therapeutics Inc
0.311
-0.238-43.30%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
53.08%-1.77M
56.07%-1.22M
31.18%-644.40K
-369.58%-1.91M
17.71%-3.78M
26.84%-2.79M
-140.80%-936.40K
-29.19%-407.62K
-1127.29%-4.59M
-518.34%-3.81M
44.32%-388.86K
78.98%-315.52K
83.46%-373.95K
---616.19K
---698.36K
---1.50M
---2.26M
Net income from continuing operations
20.16%-2.26M
89.34%-1.42M
17.27%-2.40M
96.48%-2.76M
20.24%-2.83M
-185.18%-13.34M
21.40%-2.90M
-3817.40%-78.51M
5.46%-3.54M
-137.53%-4.68M
-96.43%-3.69M
4.34%-2.00M
-75.15%-3.75M
---1.97M
---1.88M
---2.10M
---2.14M
Operating gains losses
-100.00%0.00
-100.00%0.00
-33.35%1.73K
-100.00%2.60K
0.00%2.60K
467625.19%12.16M
0.00%2.60K
3122123.23%81.18M
0.00%2.60K
0.00%2.60K
0.00%2.60K
0.00%2.60K
0.00%2.60K
--2.60K
--2.60K
--2.60K
--2.60K
Deferred tax
----
99.50%-2.96K
100.00%0.00
100.12%9.71K
100.00%0.00
20.00%-596.07K
---485.00
---7.84M
---1.05M
---745.05K
----
----
----
----
----
----
----
Other non-cash items
-6.25%81.60K
31.13%117.57K
-100.00%0.00
-100.00%0.00
294.79%87.04K
6.28%89.66K
654.81%22.82K
41543.08%1.78M
-31.50%22.05K
28.03%84.36K
102.39%3.02K
-94.90%4.29K
-60.32%32.18K
--65.89K
---126.60K
--83.94K
--81.12K
Change in working capital
126.20%330.99K
94.42%-78.18K
-6.10%1.59M
-74.10%676.68K
-306.71%-1.26M
-257.42%-1.40M
-34.08%1.70M
159.88%2.61M
-126.19%-310.56K
87.31%889.36K
1577.20%2.58M
285.88%1.01M
207.05%1.19M
--474.81K
--153.59K
---540.91K
---1.11M
-Change in prepaid expenses
51.78%-313.90K
-67.94%82.62K
-44.74%254.41K
773.68%344.57K
7.13%-651.02K
53.73%257.72K
-47.53%460.39K
107.67%39.44K
-66.76%-701.00K
307.93%167.65K
397.59%877.49K
-74680.52%-514.49K
-832.07%-420.36K
---80.63K
---294.87K
---688.00
--57.42K
-Change in other current assets
--8.39K
188.29%128.14K
---30.26K
-128.40%-80.00K
----
-165.59%-145.13K
-100.00%0.00
369.43%281.66K
-100.00%0.00
342.55%221.27K
-87.74%40.00K
116.38%60.00K
414.36%60.00K
--50.00K
--326.27K
---366.27K
--11.66K
Cash from non-recurring investing activities
Cash from operating activities
53.08%-1.77M
56.07%-1.22M
31.18%-644.40K
-369.58%-1.91M
17.71%-3.78M
26.84%-2.79M
-140.80%-936.40K
-29.19%-407.62K
-1127.29%-4.59M
-518.34%-3.81M
44.32%-388.86K
78.98%-315.52K
83.46%-373.95K
---616.19K
---698.36K
---1.50M
---2.26M
Investing cash flow
Cash from non-current investing activities
Financing cash flow
Cash flow from continuous financing activities
-30.68%1.85M
-39.43%2.63M
-71.67%647.84K
100.00%0.00
7807.50%2.67M
747.43%4.35M
244.96%2.29M
-316.52%-641.76K
-108.82%-34.67K
--512.88K
--662.80K
--296.40K
-92.48%393.30K
--0.00
--0.00
--0.00
--5.23M
Net cash flow from debt Issuance/repayment
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--5.23M
Net cash flow from common stock issuance/repurchase
----
-72.91%1.35M
----
----
----
--5.00M
--2.10M
--11.01M
----
----
----
----
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
-100.00%-1.00
-123.08%-230.00K
-1046561100.00%-10.47M
-100.00%0.00
--548.80K
--996.40K
--1.00
--419.32K
--0.00
--0.00
--0.00
--0.00
Proceeds from issuance of warrants
-25.17%2.00M
941860.89%1.69M
-14.40%827.98K
--0.00
--2.67M
--179.00
--967.30K
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
---147.13K
37.58%-407.90K
67.24%-180.14K
----
100.00%0.00
-1719.30%-653.51K
-64.85%-549.93K
-499.62%-1.18M
-33.26%-34.67K
---35.92K
---333.60K
--296.40K
---26.02K
--0.00
--0.00
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-30.68%1.85M
-39.43%2.63M
-71.67%647.84K
100.00%0.00
7807.50%2.67M
747.43%4.35M
244.96%2.29M
-316.52%-641.76K
-108.82%-34.67K
--512.88K
--662.80K
--296.40K
-92.48%393.30K
--0.00
--0.00
--0.00
--5.23M
Net cash flow
Beginning cash balance
-51.21%1.53M
-92.21%122.92K
-47.75%119.49K
59.11%2.03M
-46.84%3.14M
-84.05%1.58M
-30.45%228.69K
267.34%1.28M
1696.27%5.90M
947.75%9.90M
-79.99%328.81K
-88.93%347.93K
88.12%328.58K
--944.77K
--1.64M
--3.14M
--174.67K
Current period cash flow changes
107.30%80.61K
-9.68%1.41M
-99.75%3.44K
-82.40%-1.91M
76.12%-1.10M
147.28%1.56M
392.83%1.35M
-5389.54%-1.05M
-23997.29%-4.62M
-435.11%-3.30M
139.23%273.94K
98.73%-19.12K
-99.35%19.35K
---616.19K
---698.36K
---1.50M
--2.97M
Ending cash balance
-20.75%1.61M
-51.21%1.53M
-92.21%122.92K
-47.75%119.49K
59.11%2.03M
-52.47%3.14M
161.92%1.58M
-30.45%228.69K
267.34%1.28M
1909.10%6.60M
-36.20%602.75K
-79.99%328.81K
-88.93%347.93K
--328.58K
--944.77K
--1.64M
--3.14M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
